Investing.com - Dr. Reddy’s Labs ADR reported on Tuesday first quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Dr. Reddy’s Labs ADR announced earnings per share of 0.46 on revenue of 662M. Analysts polled by Investing.com anticipated EPS of 0.5482 on revenue of 675.18M.
Dr. Reddy’s Labs ADR shares are up 1.85% from the beginning of the year and are trading at 72.61 , down-from-52-week-high.They are outperforming the EUR/USD which is down 0% from the start of the year.
Dr. Reddy’s Labs ADR follows other major Healthcare sector earnings this month
Dr. Reddy’s Labs ADR's report follows an earnings beat by J&J on July 21, who reported EPS of 2.48 on revenue of 23.31B, compared to forecasts EPS of 2.29 on revenue of 22.49B.
UnitedHealth had beat expectations on July 15 with second quarter EPS of 4.7 on revenue of 71.32B, compared to forecast for EPS of 4.43 on revenue of 69.51B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar